Acadian Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.7M Buy
623,004
+57,959
+10% +$1.09M 0.02% 400
2025
Q1
$10.2M Buy
565,045
+188,679
+50% +$3.39M 0.03% 329
2024
Q4
$6.33M Sell
376,366
-45,414
-11% -$764K 0.02% 453
2024
Q3
$6.82M Sell
421,780
-128,358
-23% -$2.08M 0.02% 420
2024
Q2
$4.52M Buy
550,138
+3,620
+0.7% +$29.7K 0.01% 529
2024
Q1
$8.09M Buy
546,518
+84,342
+18% +$1.25M 0.03% 357
2023
Q4
$6.7M Sell
462,176
-3,898
-0.8% -$56.5K 0.03% 382
2023
Q3
$5.03M Buy
466,074
+7,923
+2% +$85.6K 0.02% 433
2023
Q2
$5.91M Buy
458,151
+85,795
+23% +$1.11M 0.02% 411
2023
Q1
$4.91M Buy
372,356
+18,206
+5% +$240K 0.02% 459
2022
Q4
$5.31M Buy
354,150
+134,964
+62% +$2.02M 0.03% 425
2022
Q3
$2.58M Sell
219,186
-2,641
-1% -$31.1K 0.01% 561
2022
Q2
$2.51M Buy
221,827
+140,548
+173% +$1.59M 0.01% 572
2022
Q1
$2.43M Buy
81,279
+22,742
+39% +$680K 0.01% 622
2021
Q4
$1.55M Buy
+58,537
New +$1.55M 0.01% 721
2021
Q1
Sell
-16,964
Closed -$594K 2285
2020
Q4
$594K Sell
16,964
-103,669
-86% -$3.63M ﹤0.01% 1172
2020
Q3
$2.9M Sell
120,633
-20,472
-15% -$491K 0.01% 567
2020
Q2
$2.58M Buy
141,105
+9,752
+7% +$179K 0.01% 665
2020
Q1
$2.05M Buy
131,353
+37,790
+40% +$589K 0.01% 598
2019
Q4
$2M Buy
93,563
+61,156
+189% +$1.31M 0.01% 688
2019
Q3
$606K Buy
32,407
+6,979
+27% +$131K ﹤0.01% 1030
2019
Q2
$663K Buy
25,428
+21,506
+548% +$561K ﹤0.01% 924
2019
Q1
$101K Buy
+3,922
New +$101K ﹤0.01% 1515
2016
Q4
Sell
-13,248
Closed -$486K 1750
2016
Q3
$486K Buy
+13,248
New +$486K ﹤0.01% 819
2016
Q2
Sell
-16,895
Closed -$351K 1508
2016
Q1
$351K Buy
16,895
+14,947
+767% +$311K ﹤0.01% 811
2015
Q4
$59K Buy
1,948
+1,907
+4,651% +$57.8K ﹤0.01% 1114
2015
Q3
$1K Sell
41
-465
-92% -$11.3K ﹤0.01% 1276
2015
Q2
$16K Buy
506
+91
+22% +$2.88K ﹤0.01% 1105
2015
Q1
$15K Buy
+415
New +$15K ﹤0.01% 1142